Cloud Banner

Healthcare

Image

Global Biopharmaceuticals Market – Industry Trends and Forecast to 2030

  • Healthcare
  • Upcoming Report
  • Jun 2023
  • Global
  • 350 Pages
  • No of Tables: 60
  • No of Figures: 220

Global Biopharmaceuticals Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR - 12.4% Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 915.60 Million
Diagram Market Size (Forecast Year) USD 2332.57 Million
Diagram CAGR 12.4%

Global Biopharmaceuticals Market, By Product Type (Monoclonal Antibodies, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormone, Vaccines, Synthetic Immunomodulatory, and Other), Service (Laboratory Testing, Custom Testing / Customer Proprietary Testing, Compendial, and Multi Compendial Laboratory Testing), Raw Material Type (Formulation Excipients, Active Pharmaceutical Ingredients (API), and Compendial Methods (USP / EP / JP) Based Vendor Qualification Program Support), Application (Oncology, Inflammatory and Infectious Diseases, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders, Cardiovascular Diseases, Neurological Diseases, and Other) – Industry Trends and Forecast to 2030.

Biopharmaceuticals Market

Biopharmaceuticals market Analysis and Size

Rising chronic diseases and a growing geriatric population have carved the way for the growth of the biopharmaceutical market. Biopharmaceuticals have revolutionized the treatment of chronic diseases such as cancer, autoimmune disorders, and genetic disorders. They offer targeted therapies that can selectively act on specific disease pathways, providing improved efficacy and reduced side effects compared to traditional small molecule drugs.

Data Bridge Market Research analyses that the global biopharmaceuticals market which was USD 915.6 million in 2022, would rocket up to USD 2,332.57 million by 2030, and is expected to undergo a CAGR of 12.40% during the forecast period. This indicates that monoclonal antibodies dominate the product type segment of the biopharmaceuticals market owing to the growing demand for the global biopharmaceuticals market. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Biopharmaceuticals market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customisable 2015-2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, and Pricing in USD

Segments Covered

By Product Type (Monoclonal Antibodies, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormone, Vaccines, Synthetic Immunomodulatory, and Other), Service (Laboratory Testing, Custom Testing / Customer Proprietary Testing, Compendial, and Multi Compendial Laboratory Testing), Raw Material Type (Formulation Excipients, Active Pharmaceutical Ingredients (API), and Compendial Methods (USP / EP / JP) Based Vendor Qualification Program Support), Application (Oncology, Inflammatory and Infectious Diseases, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders, Cardiovascular Diseases, Neurological Diseases, and Other)

Countries Covered

U.S., Canada,  Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina and Rest of South America

Market Players Covered

Amgen Inc. (U.S.), Lilly (U.S), Johnson & Johnson Private Limited (U.S.), Sanofi (France), Abbott (U.S), AstraZeneca (U.K.),  Amgen Inc. (U.S.), F. Hoffmann-La Roche Ltd., (Switzerland), bioMérieux (France), Novartis AG (Switzerland), Bristol-Myers Squibb Company (U.S.), Novo Nordisk A/S (Denmark), Merck & Co., Inc. (U.S.), GlaxoSmithKline Plc (U.K.), Biogen (U.S.), Bayer AG (Germany) and Pfizer Inc., (U.S.)

Market Opportunities

  • Rise in personalized medicine and precision therapeutics
  • Increasing rare diseases and orphan drugs

Market Definition

Biopharmaceuticals, also known as biologic drugs or biologics, are medical products derived from biological sources such as living organisms, cells, or proteins. These drugs are produced using biotechnology processes and play a crucial role in modern healthcare. Biopharmaceuticals have enabled the development of personalized medicine approaches. These drugs can be designed to target specific molecular characteristics of an individual's disease, allowing for tailored treatment strategies based on the patient's unique genetic profile or disease subtype.         

Global biopharmaceuticals market Dynamics

Drivers

  • Rising demand for biopharmaceuticals

Chronic diseases such as cancer, autoimmune disorders, diabetes, and cardiovascular diseases continue to rise globally. Biopharmaceuticals offer advanced treatment options that specifically target the underlying causes of these complex diseases, providing improved therapeutic outcomes and enhanced patient care.

  • Research and development proficiencies

Rising expenditure for research and development proficiencies especially in the developed and developing economies pertaining to the medical instruments and devices will further create lucrative market growth opportunities. Research and development proficiencies being conducted to develop the medical instruments is also bolstering the market growth rate.

  • Growing investment for healthcare facilities

Surging focus towards improving the condition of healthcare facilities and improving the overall healthcare infrastructure another important factor fostering the growth of the market. Rising number of partnerships and strategic collaborations between the public and private players pertaining to funding and application of new and improved technology is further creating lucrative market opportunities.  

Opportunities

  • Rise in personalized medicine and precision therapeutics

The field of personalized medicine is rapidly evolving, driven by advancements in genomics, molecular diagnostics, and biomarker identification. Biopharmaceutical companies have the opportunity to develop targeted therapies that align with the principles of precision medicine, tailoring treatments to the specific genetic and molecular characteristics of individual patients.

  • Increasing rare diseases and orphan drugs

Orphan drugs, which are developed to treat rare diseases, represent an area of opportunity in the biopharmaceutical market. These conditions often have limited treatment options, creating a demand for innovative therapies. Biopharmaceutical companies can focus on developing targeted biologics for rare diseases, benefiting from regulatory incentives and addressing unmet medical needs.

Restraints

  • Underdiagnoses and Lack of Awareness

Xerostomia is often underdiagnosed and underreported, primarily due to a lack of awareness among both healthcare professionals and the general population. Many individuals may not recognize the symptoms or consider them significant enough to seek medical attention. This can hinder the growth of the xerostomia market as it limits the identification and treatment of affected individuals.

Challenges

  • Side Effects and Safety Concerns

Some medications used for treating xerostomia or associated conditions may have side effects or interactions that limit their use or pose safety concerns. Additionally, patients with certain medical conditions or those taking multiple medications may have limited treatment options due to potential contraindications or adverse effects.

This global biopharmaceuticals market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global biopharmaceuticals market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

  • In February 2021, Bristol Myers Squibb and The Rockefeller University have announced the signing of a definitive agreement under which Bristol Myers Squibb has been granted a worldwide exclusive licence to develop, manufacture, and market Rockefeller's novel monoclonal antibody ("mAb") duo treatment that neutralises the SARS-CoV-2 virus for COVID therapy or prevention. This innovative treatment combines two monoclonal antibodies (mAbs) that block the SARS-CoV-2 spike protein and neutralise the virus.
  • In March 2023, F. Hoffmann-La Roche Ltd announced that it has entered into a collaboration with Eli Lilly and Company to support the development of Roche’s Elecsys Amyloid Plasma Panel (EAPP). The EAPP is an innovative blood test that aims to facilitate the earlier diagnosis of Alzheimer’s disease.

Global Biopharmaceuticals Market Scope

The global biopharmaceuticals market is segmented on the basis of product type, services, raw material, compendial methods and application. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

  • Monoclonal Antibodies
  • Recombinant Growth Factors
  • Purified Proteins
  • Recombinant Proteins
  • Recombinant Hormone
  • Vaccines
  • Synthetic Immunomodulators
  • Other

Service

  • Laboratory Testing, Custom Testing / Customer Proprietary Testing
  • Compendial and Multi Compendial Laboratory Testing

Raw Material Type

Application

  • Oncology
  • Inflammatory and Infectious Diseases
  • Autoimmune Disorders
  • Metabolic Disorders
  • Hormonal Disorders
  • Cardiovascular Diseases
  • Neurological Diseases
  • Other

Global biopharmaceuticals market Regional Analysis/Insights

The global biopharmaceuticals market is analysed and market size insights and trends are provided by product type, services, raw material, compendial methods, and application, as referenced above.

The countries covered in the global biopharmaceuticals market report are U.S., Canada,  Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina, and rest of South America.

North America dominates the global biopharmaceuticals market because of the strong base of healthcare facilities, and availability of advanced treatment options that specifically target the underlying causes of these complex diseases, providing improved therapeutic outcomes and enhanced patient care in this region.   

Asia-Pacific is expected to witness significant growth during the forecast period of 2023 to 2030 due to the increase in government initiatives to promote awareness, rising technological advancements, and the growing demand for quality healthcare in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The global biopharmaceuticals market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for global biopharmaceuticals market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the global biopharmaceuticals market. The data is available for historic period 2010-2020.

Competitive Landscape and Global biopharmaceuticals market Share Analysis

The global biopharmaceuticals market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to the market.

Some of the major players operating in the global biopharmaceuticals market are:

  • Amgen Inc. (U.S.)
  • Lilly (U.S)
  •  Johnson & Johnson Private Limited (U.S.)
  • Sanofi (France)
  • Abbott (U.S.)
  • AstraZeneca (U.K.)
  • Amgen Inc. (U.S.)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • bioMérieux (France)
  • Novartis AG (Switzerland)
  • Bristol-Myers Squibb Company (U.S.)
  • Novo Nordisk A/S (Denmark)
  • Merck & Co., Inc. (U.S.)
  • GlaxoSmithKline Plc (U.K.)
  • Biogen (U.S.)
  • Bayer AG (Germany)
  • Pfizer Inc., (U.S.)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The biopharmaceuticals market size will be worth USD 2,332.57 million by 2030.
The growth rate of the biopharmaceuticals market is 12.40% in the forecast period by 2030.
Product type, services, raw material, compendial methods, and application are the factors on which the biopharmaceuticals market research is based.
Rising demand for biopharmaceuticals, Research and development proficiencies & Growing investment for healthcare facilities are the growth drivers of the biopharmaceuticals market.
Major companies in the biopharmaceuticals market are Amgen Inc. (U.S.), Lilly (U.S), Johnson & Johnson Private Limited (U.S.), Sanofi (France), Abbott (U.S), AstraZeneca (U.K.), Amgen Inc. (U.S.), F. Hoffmann-La Roche Ltd., (Switzerland), bioMérieux (France), Novartis AG (Switzerland), Bristol-Myers Squibb Company (U.S.), Novo Nordisk A/S (Denmark), Merck & Co., Inc. (U.S.), GlaxoSmithKline Plc (U.K.), Biogen (U.S.), Bayer AG (Germany) and Pfizer Inc., (U.S.).
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials